Lagura, Blaze .

HRN: 27-35-41  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/20/2025
METRONIDAZOLE 125MG/5ML, 60ML (BOT)
06/20/2025
06/27/2025
PO
5mL
TID
Intestinal Amoebiasis With Mod DHN
Checking Initial Appropriateness 
06/22/2025
MEBENDAZOLE 100MG/5ML, 60ML SUSPENSION
06/22/2025
06/25/2025
PO
5ml
BID
Ascariasis Infection
Checking Initial Appropriateness 
06/23/2025
CEFUROXIME 750MG (VIAL)
06/23/2025
06/30/2025
IV
350mg
Q8
Acute Bacterial Infection
Checking Initial Appropriateness 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: